story of the week
Trilaciclib Plus Chemotherapy vs Chemotherapy Alone in Patients With Metastatic Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trilaciclib Plus Chemotherapy Versus Chemotherapy Alone in Patients With Metastatic Triple-Negative Breast Cancer: A Multicentre, Randomised, Open-Label, Phase 2 Trial
Lancet Oncol 2019 Sep 27;[EPub Ahead of Print], AR Tan, GS Wright, AR Thummala, MA Danso, L Popovic, TJ Pluard, HS Han, Ž Vojnović, N Vasev, L Ma, DA Richards, ST Wilks, D Milenković, Z Yang, JM Antal, SR Morris, J O'ShaughnessyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.